Page last updated: 2024-10-17

citric acid, anhydrous and Chronic Inflammatory Demyelinating Polyradiculoneuropathy

citric acid, anhydrous has been researched along with Chronic Inflammatory Demyelinating Polyradiculoneuropathy in 1 studies

Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.

Research Excerpts

ExcerptRelevanceReference
"For the CIDP group, 90% of sessions achieved a plasma volume >1 TPV, and for the FH group 91% of sessions achieved an LDLc reduction >60%."1.91Feasibility, Efficacy, and Safety of Peripheral Venous Access for Chronic Double-Filtration Plasmapheresis with Regional Citrate Anticoagulation. ( Cardinale, A; Messikh, Z; Moranne, O; Pambrun, E; Prelipcean, C, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cardinale, A1
Pambrun, E1
Prelipcean, C1
Messikh, Z1
Moranne, O1

Other Studies

1 other study available for citric acid, anhydrous and Chronic Inflammatory Demyelinating Polyradiculoneuropathy

ArticleYear
Feasibility, Efficacy, and Safety of Peripheral Venous Access for Chronic Double-Filtration Plasmapheresis with Regional Citrate Anticoagulation.
    Blood purification, 2023, Volume: 52, Issue:7-8

    Topics: Adult; Anticoagulants; Citric Acid; Feasibility Studies; Female; Humans; Male; Plasmapheresis; Polyr

2023